|
|
Article: Protalix BioTherapeutics to Present at the Oppenheimer 20th Annual Healthcare Conference.(Conference news)
- Article from:
- Gene Therapy Weekly
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX), announced that Dr. David Aviezer, President and CEO, will present at the Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, 2009 at 1:35 PM ET. The conference is being held at the Waldorf Astoria Hotel in New York (see also Protalix BioTherapeutics, Inc.).
An audio webcast of the corporate presentation will be available on Protalix's website at www.protalix.com under the events calendar section. About Protalix BioTherapeutics Protalix is a biopharmaceutical company. Its goal is to become a fully integrated biopharmaceutical company focused on the development and commercialization of proprietary ...